These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36647996)

  • 1. Pauci-immune Lupus Nephritis in Antiphospholipid Disease: A Diagnostic Challenge.
    Alhemyadi SA; Al-Hamidi AA; Asiri S; Al-Swailem R
    Saudi J Kidney Dis Transpl; 2022; 33(1):196-200. PubMed ID: 36647996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome.
    Nagata H; Sato M; Ogura M; Yoshikawa T; Yamamoto K; Matsumura S; Kano Y; Saida K; Sako M; Kamei K; Yoshioka T; Ogata K; Ito S; Ishikura K
    Nephrology (Carlton); 2018 Jun; 23(6):592-596. PubMed ID: 28976051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.
    Kotzen ES; Roy S; Jain K
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal involvement in antiphospholipid syndrome.
    de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM
    Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
    Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients.
    Jordan N; Chaib A; Sangle S; Tungekar F; Sabharwal T; Abbs I; Khamashta M; D'Cruz D
    Arthritis Care Res (Hoboken); 2014 May; 66(5):725-31. PubMed ID: 24127353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid Syndrome and the Kidney.
    Sciascia S; Baldovino S; Schreiber K; Solfietti L; Roccatello D
    Semin Nephrol; 2015 Sep; 35(5):478-86. PubMed ID: 26573550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catastrophic antiphospholipid syndromes in systemic lupus erythematosus.
    Stratta P; Canavese C; Ferrero S; Grill A; Salomone M; Schinco PC; Fusaro E; Montaruli B; Santi S; Piccoli G
    Ren Fail; 1999 Jan; 21(1):49-61. PubMed ID: 10048117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Hughson MD; Nadasdy T; McCarty GA; Sholer C; Min KW; Silva F
    Am J Kidney Dis; 1992 Aug; 20(2):150-8. PubMed ID: 1496968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics.
    Nielly H; Mathian A; Cazenave M; Izzedine H; Haroche J; Cohen-Aubart F; Hie M; Miyara M; Pineton de Chambrun M; Benameur N; Hausfater P; Pha M; Boutin-Lê Thi Huong D; Rouvier P; Brocheriou I; Cluzel P; Amoura Z
    Nephrol Dial Transplant; 2020 Oct; 35(10):1721-1729. PubMed ID: 31157889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.
    Horita S; Zoshima T; Hara S; Koichi M; Hirayama S; Suzuki K; Nakashima A; Kawano M
    CEN Case Rep; 2021 Aug; 10(3):409-413. PubMed ID: 33595828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-phospholipid syndrome nephropathy].
    Nochy D; Daugas E; Hill G; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature.
    Stanescu C; Andronesi AG; Jurcut C; Gherghiceanu M; Vornicu A; Burcea FA; Andronesi TD; Lupusoru GE; Iliuta L; Sorohan BM; Obrisca B; Ismail G
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lupus nephritis and thrombotic microangiopathy: A review].
    Bobrova LA; Kozlovskaya NL
    Ter Arkh; 2024 Jul; 96(6):628-634. PubMed ID: 39106505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Domingues V; Chock EY; Dufrost V; Risse J; Seshan SV; Barbhaiya M; Sartelet H; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2022 Oct; 21(10):103158. PubMed ID: 35907609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
    Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
    Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
    Lopez-Pedrera C; Patiño-Trives AM; Cerdó T; Ortega-Castro R; Sanchez-Pareja I; Ibañez-Costa A; Muñoz-Barrera L; Ábalos-Aguilera MC; Ruiz-Vilchez D; Seguí Azpilcueta P; Espinosa M; Barbarroja N; Escudero-Contreras A; Castaño JP; Luque RM; Ortega R; Aguirre MA; Perez-Sanchez C
    J Autoimmun; 2023 Feb; 135():102990. PubMed ID: 36621176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.